Literature DB >> 24408938

Skin nodules in a patient with acute lymphoblastic leukaemia.

Lenaïg Le Clech1, Pascal Hutin, Solène Le Gal, Gaëlle Guillerm.   

Abstract

Opportunistic infections cause a significant morbidity and mortality in immunocompromised patients. We describe the case of a patient with skin fusariosis and a probable cerebral toxoplasmosis after UCB stem cell transplantation for B-cell acute lymphoblastic leukaemia. Fusarium species (spp) infections are difficult to treat. To date, there has been no consensus on the treatment of fusariosis and the management of its side effects. Given the negative pretransplant Toxoplasma serology in this case, identifying the origin of the Toxoplasma infection was challenging. All usual transmission routes were screened for and ruled out. The patient's positive outcome was not consistent with that of the literature reporting 60% mortality due to each infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24408938      PMCID: PMC3903090          DOI: 10.1136/bcr-2013-010481

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis.

Authors:  Prithviraj Bose; Hiral D Parekh; Jennifer L Holter; Ronald A Greenfield
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.

Authors:  Laura Cudillo; Corrado Girmenia; Stefania Santilli; Alessandra Picardi; Teresa Dentamaro; Andrea Tendas; Paolo de Fabritiis
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

3.  International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Authors:  Olivier Lortholary; Gaelle Obenga; Pinaki Biswas; Denis Caillot; Elisabeth Chachaty; Anne-Lise Bienvenu; Muriel Cornet; John Greene; Raoul Herbrecht; Claire Lacroix; Frédéric Grenouillet; Issam Raad; Karine Sitbon; Peter Troke
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

4.  Toxoplasmosis in cord blood transplantation recipients.

Authors:  G Bautista; A Ramos; R Forés; C Regidor; E Ruiz; A de Laiglesia; B Navarro; J Bravo; F Portero; I Sanjuan; M N Fernández; R Cabrera
Journal:  Transpl Infect Dis       Date:  2012-05-01       Impact factor: 2.228

5.  Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.

Authors:  Marcela Campo; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2010-02-04       Impact factor: 6.072

6.  Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Authors:  Issam I Raad; Ray Y Hachem; Raoul Herbrecht; John R Graybill; Roberta Hare; Gavin Corcoran; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

Review 7.  Treating disseminated fusariosis: amphotericin B, voriconazole or both?

Authors:  Dora Y Ho; Jason D Lee; Fernando Rosso; Jose G Montoya
Journal:  Mycoses       Date:  2007-05       Impact factor: 4.377

8.  Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.

Authors:  Anna Maria Tortorano; Anna Prigitano; Giovanna Dho; Maria Carmela Esposto; Claudia Gianni; Anna Grancini; Cristina Ossi; Maria Anna Viviani
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 9.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

10.  In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.

Authors:  Susana Córdoba; Laura Rodero; Walter Vivot; Rubén Abrantes; Graciela Davel; Roxana G Vitale
Journal:  Int J Antimicrob Agents       Date:  2007-12-03       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.